Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT05678348 · COMPLETED

Trial details

NCT number: NCT05678348
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer Cancer of the Head and Neck

Start date: 2023-08-03
Primary completion: 2025-07-11
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.